Supplementary
17.33% 0.758 *maximum over the 200 top-prioritized covariates identified by the HDPS algorithm **SMD: absolute standardized mean difference. The weighted standardized mean difference measures the imbalance in characteristics between patients treated with branded and generic drugs. After inverse probability of treatment weighting to increase balance, a value lower than 10% is usually considered as indicating adequate balance. ***C-index: concordance index of the high-dimensional propensity score model. The c-index measures the discriminative ability of the propensity model. It expresses the probability that in a randomly selected pair of patients, one treated with a branded, one with a generic drug, the patient treated with the branded drug has a higher estimated probability to receive a branded drug. A value of 0.5 indicates random treatment assignment, while a value of 1 indicates perfect predictability of treatment assignment from the patient characteristics.
